CHASITY TIERNEY: Open Payments
NPI 1811304744 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$443 in 15 payments from 11 companies in 2025. Trend: 2023 $225 · 2024 $128 · 2025 $443
Food & beverage: $443
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Veloxis Pharmaceuticals, Inc. | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| One Lambda, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: Ozempic, LIVTENCITY, ENVARSUS, ACTHAR, JYNARQUE, KRYSTEXXA, PREVYMIS, GIVLAARI.
Industry payments across GA — which companies pay providers there.
